United Therapeutics (UTHR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$487.61-0.54%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · UTHR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 3,154.5 | 3,182.7 | 2,877.4 | 2,327.5 | 1,936.3 | 1,685.5 | 1,483.3 | 1,448.8 | 1,627.8 | 1,725.3 | 1,598.8 | 1,465.8 | 1,288.5 | 1,117.0 | 916.1 | 743.2 | 592.9 |
| Total Revenues | — | — | — | — | — | — | 1,483.3 | 1,448.8 | 1,627.8 | 1,725.3 | 1,598.8 | 1,465.8 | 1,288.5 | 1,117.0 | 916.1 | 743.2 | 592.9 |
| Cost of Revenues | 437.2 | 384.4 | 309.7 | 257.5 | 151.6 | 122.5 | 108.1 | 117.6 | 198.7 | — | — | — | — | — | — | — | — |
| Gross Profit | 2,717.3 | 2,798.3 | 2,567.7 | 2,070.0 | 1,784.7 | 1,563.0 | 1,375.2 | — | — | — | — | — | 1,153.7 | 975.8 | 786.8 | 652.2 | — |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 764.0 | 755.8 | 709.7 | 477.1 | 482.1 | 467.0 | — | — | 265.8 | 330.1 | 316.8 | 452.7 | 381.3 | 394.0 | 201.7 | 156.5 | 188.6 |
| R&D Expenses | 551.5 | 550.0 | 481.0 | 408.0 | 322.9 | 540.1 | 357.7 | 1,182.6 | 357.9 | 264.6 | 147.6 | 245.1 | 242.5 | 299.3 | 173.4 | 180.0 | 165.3 |
| Operating Income | 1,401.8 | 1,492.5 | 1,377.0 | 1,184.9 | 979.7 | 555.9 | 593.6 | (187.6) | 805.4 | 814.9 | 1,061.7 | 699.0 | 538.8 | 292.5 | 421.6 | 317.8 | 171.3 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 19.5 | 42.9 | 59.3 | 32.4 | 18.6 | 23.5 | 44.2 | 13.9 | 9.0 | 3.9 | 4.7 | 17.6 | 18.1 | 16.6 | 21.4 | 19.7 |
| Interest & Investment Income | 162.9 | 192.0 | 199.1 | 162.7 | 45.2 | 16.7 | 28.6 | 44.2 | 28.6 | — | — | — | — | 3.8 | 3.9 | 3.5 | 2.9 |
| Net Interest Expenses | — | — | — | (103.4) | (12.8) | 1.9 | (5.1) | 0.0 | (14.7) | — | — | — | — | 14.2 | 12.7 | 17.9 | 16.8 |
| Other Non-Operating Income / Expenses | 171.2 | 221.4 | 162.0 | 89.4 | (29.1) | 38.0 | 45.3 | 22.6 | (46.5) | (45.4) | (1.5) | 345.4 | (13.6) | (13.6) | 19.0 | (18.7) | (16.2) |
| Asset Writedown | — | — | — | — | — | — | 5.4 | 17.2 | — | — | — | — | 6.8 | 6.8 | 6.8 | 7.7 | — |
| EBT, Incl. Unusual Items | 1,573.0 | 1,713.9 | 1,539.0 | 1,274.3 | 950.6 | 593.9 | 638.9 | (165.0) | 758.9 | 769.5 | 1,060.2 | 1,044.4 | 525.2 | 278.9 | 440.7 | 299.1 | — |
| Income Tax Expense | 262.1 | 379.2 | 343.9 | 289.5 | 223.3 | 118.1 | 124.1 | (60.5) | 169.7 | 351.6 | 346.5 | 392.8 | 185.1 | 104.3 | 136.2 | 81.9 | 43.9 |
| Net Income | |||||||||||||||||
| Net Income | 1,310.9 | 1,334.7 | 1,195.1 | 984.8 | 727.3 | 475.8 | 514.8 | (104.5) | 589.2 | 417.9 | 713.7 | 651.6 | 340.1 | 174.6 | 304.4 | 217.9 | 105.9 |
| Per Share | |||||||||||||||||
| Basic EPS | 30.77 | 30.13 | 26.44 | 21.04 | 15.98 | 10.60 | 11.65 | (2.39) | 13.54 | 9.50 | 16.29 | 14.17 | 7.06 | 3.49 | 5.84 | 3.81 | 1.89 |
| Diluted EPS | 28.62 | 27.86 | 24.64 | 19.81 | 15.00 | 10.06 | 11.54 | (2.39) | 13.39 | 9.31 | 15.25 | 12.72 | 6.28 | 3.28 | 5.71 | 3.67 | 1.78 |
| Revenue per Share | 68.88 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 42.6 | 44.3 | 45.2 | 46.8 | 45.5 | 44.9 | 44.2 | 43.8 | 43.5 | 44.0 | 43.8 | 46.0 | 48.2 | 50.1 | 52.1 | 57.2 | 56.1 |
| Diluted Weighted Avg Shares | 45.8 | 47.9 | 48.5 | 49.7 | 48.5 | 47.3 | 44.6 | 43.8 | 44.0 | 44.9 | 46.8 | 51.2 | 54.2 | 53.2 | 53.3 | 59.4 | 59.5 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 1,578.1 | 1,449.5 | 1,238.1 | 1,031.0 | 605.8 | 643.5 | (141.7) | 841.3 | 845.9 | 1,093.3 | 731.9 | 571.0 | 323.8 | 448.8 | 338.3 | 189.2 |
| EBIT | 1,401.8 | 1,492.5 | 1,377.0 | 1,184.9 | 979.7 | 555.9 | 593.6 | (187.6) | 805.4 | 814.9 | 1,061.7 | 699.0 | 538.8 | 292.5 | 421.6 | 317.8 | 171.3 |
| Effective Tax Rate | 16.7% | — | — | 22.7% | 23.5% | 19.9% | 19.4% | 36.7% | 22.4% | 45.7% | 32.7% | 37.6% | 35.2% | 37.4% | 30.9% | 27.4% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.